A., Rolf, T
Supplementary material The Supplementary Material for this article can be found online at: Abbreviations Angptl4 Angiopoietin-Like 4 bLPL bovine LPL BSA Bovine Serum Albumin CVD cardiovascular disease CXN calnexin EL endothelial lipase ER endoplasmic reticulum fAngptl4 full-length Angptl4 FFA free fatty acids GPIHBP1 glycosylphosphatidylinositol-anchored high-density lipoproteinbinding protein 1 HDX-MS Hydrogen Deuterium Exchange Mass Spectrometry HL hepatic lipase HR heparin release HTG hypertriglyceridemia KRP Krebs Ringer Phosphate LMF1 lipase maturation factor LPL lipoprotein lipase nAngptl4 N-terminal domain Angptl4 PC proprotein convertase PHP post-heparin plasma SorLA sortilin-related receptor with type-A repeats TG triglyceride TRL TG-rich lipoproteins VLDL very-low density lipoproteins

For example, a comparative study conducted on the anti-tumor efficacy of the antibodydrug conjugates (ADCs) with cetuximab, which is an anti-epidermal growth factor receptor (EGFR) antibody, guided avidin-nucleic-acid nano assemblies (ANANAS), reported that cetuximab guidance for ANANAS significantly enhanced the drug-antibody ratio as compared to ADCs [206]
Chevalier B, Pasquier D, Lartigau EF, Chargari C, Schernberg A, Jannin A, Mirabel X, Vantyghem MC, Escande A
(2) where applicable and publicly available, identifying patents asserted in litigation (in the U.S and Europe) in relation to a product
R., Bozorgi, M., & Khazaei, M